Showing Results for
- Academic Journals (76)
Search Results
- 76
Academic Journals
- 76
-
From:Clinical Pharmacokinetics (Vol. 46, Issue 9) Peer-ReviewedWe appreciate the interest that Gardiner et al. took in our recent article on thiopurine treatment in inflammatory bowel disease. [1] Importantly, the incidence of inflammatory bowel disease peaks during the...
-
From:Clinical Pharmacokinetics (Vol. 46, Issue 3) Peer-ReviewedThis review summarises clinical pharmacological aspects of thiopurines in the treatment of chronic inflammatory bowel disease (IBD). Current knowledge of pharmacogenetically guided dosing is discussed for...
-
From:Proceedings of the National Academy of Sciences of the United States (Vol. 108, Issue 7) Peer-ReviewedAbstract Only
-
From:Expert Review of Molecular Diagnostics (Vol. 13, Issue 4) Peer-ReviewedAuthor(s): Pilar H Saladores [[double dagger]] 1 , Jana C Precht [[double dagger]] 1 , Werner Schroth 1 , Hiltrud Brauch 1 , Matthias Schwab [*] 2 Keywords : anastrozole; aromatase inhibitors; CYP2D6; endocrine...
-
From:Proceedings of the National Academy of Sciences of the United States (Vol. 102, Issue 50) Peer-ReviewedAbstract Only
-
From:Clinical Pharmacokinetics (Vol. 46, Issue 4) Peer-ReviewedBackground and objective: The BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone) chemotherapy regimen for the treatment of advanced Hodgkin's lymphoma has a superior...
-
From:PLoS ONE (Vol. 7, Issue 12) Peer-ReviewedBackground Tumor necrosis factor alpha (TNF) is able to kill cancer cells via receptor-mediated cell death requiring adenosine triphosphate (ATP). Clinical usage of TNF so far is largely limited by its profound...
-
From:Pharmacogenomics (Vol. 9, Issue 9) Peer-ReviewedAuthor(s): Tobias Geisler 1 , Elke Schaeffeler 2 , Juergen Dippon 3 , Stefan Winter 4 , Verena Buse 4 , Christian Bischofs 4 , Christine Zuern 4 , Klaus Moerike 4 , Meinrad Gawaz 4 , Matthias Schwab [[dagger]] 4...
-
From:Journal of Neurology, Neurosurgery and Psychiatry (Vol. 88, Issue 8) Peer-ReviewedCitation Only
-
From:Pharmacogenomics (Vol. 14, Issue 12) Peer-ReviewedAuthor(s): Tarek Magdy 1 , Rudolf Arlanov 1 , Stefan Winter 1 , Thomas Lang 1 , Kathrin Klein 1 , Yu Toyoda 2 , Toshihisa Ishikawa 3 , Matthias Schwab 1 4 , Ulrich M Zanger [*] 5 KEYWORDS : 5-fluorouracil;...
-
From:Clinical Pharmacokinetics (Vol. 46, Issue 8) Peer-ReviewedTumor necrosis factor-[alpha] (TNF[alpha]) is a key proinflammatory cytokine involved in chronic inflammatory diseases. Infliximab, a chimeric (human-murine) monoclonal IgGl anti-TNF[alpha] antibody, is used in the...
-
From:PLoS ONE (Vol. 4, Issue 2) Peer-ReviewedReduced expression of Paneth cell antimicrobial [alpha]-defensins, human defensin (HD)-5 and -6, characterizes Crohn's disease (CD) of the ileum. TCF-4 (also named TCF7L2), a Wnt signalling pathway transcription factor,...